Home › Modalities › Peptide
Peptide (8 companies)
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| AKTS | Aktis Oncology, Inc. | Oncology | 7 | Phase 1 | 9 |
| ALT | Altimmune, Inc. | GI/HepatologyMetabolicNeurology | 3 | Phase 2 | 3 |
| AMLX | Amylyx Pharmaceuticals, Inc. | MetabolicNeurology Rare | 3 | Phase 3 | 5 |
| GLSI | Greenwich LifeSciences, Inc. | Oncology | 1 | Phase 3 | 1 |
| NGEN | NERVGEN PHARMA CORP. | Neurology | 2 | Preclinical | 2 |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | Metabolic Rare | 12 | Approved | 13 |
| SLS | SELLAS Life Sciences Group, Inc. | Oncology | 5 | Phase 3 | 8 |
| VKTX | Viking Therapeutics, Inc. | GI/HepatologyMetabolicNeurology Rare | 2 | Phase 3 | 9 |
No companies match.